Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/2358
Full metadata record
DC FieldValueLanguage
dc.contributor.authorArtikbayev M.A., Ахmedov X.S., Хalmetovа F.I.-
dc.date.accessioned2025-11-12T07:02:14Z-
dc.date.available2025-11-12T07:02:14Z-
dc.date.issued2025-
dc.identifier.issn2181-7812-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/2358-
dc.description.abstractMaqsad: reaktiv artritli bemorlarda sitokin profilini o’rganish. Material va usullar: tadqiqotga 20 yoshdan 54 yoshgacha bo’lgan reaktiv artritli 184 bemor (o’rtacha yoshi 32,3 ± 10,2 yil) va 20 nafar sog’lom nazorat guruhi ishtirokchi lari jalb qilindi. kasallikning o’rtacha davomiyligi 3,7±1,8 yil. 112 bemorda spondilit bor edi. Natijalar: olingan ma’lumot larga ko’ra, IL-17A darajasi juda katta farq qiladi: sog’lom er kaklarda bu ko’rsatkich 62,4±11,24 ng/ml ni tashkil etgan, be morlarda esa 173,3±35,2 ng/ml gacha ko’tarilgan (p>0,002). Xulosa: reaktiv artritning dastlabki bosqichlaridan boshlab IL-17A darajasining oshishi, kasallikning rivojlanishi bilan uning ko’payishi va uning dastlabki bosqichlaridan spondil itning shakllanishi o’zaro bog’liqdir. Bundan tashqari, IL-17A miqdorining ko’payishi umurtqa pog’onasining shikastlanishi ushbu kasallikning urogenital shakli va surunkali kursi uchun ko’proq xarakterli ekanligini ko’rsatadi.en_US
dc.language.isootheren_US
dc.publisherO'zbekiston, Toshkenten_US
dc.relation.ispartofseriesUO’K:;616.085-72-002.77:616-002.77-
dc.subjectreaktiv artrit,citokinlar, bo‘g‘im sin dromi, IL-17Aen_US
dc.titleREAKTIV ARTRITNING IMMUNOLOGIK JIHATLARIen_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
Махаллий март макола 25.pdfREAKTIV ARTRITNING IMMUNOLOGIK JIHATLARI972.69 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.